The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Vax Hesitancy? Myths & Facts for Patients

Vax Hesitancy? Myths & Facts for Patients

December 16, 2021 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Lia Kos / shutterstock.com

Lia Kos / shutterstock.com

Although more than 189,300,000 eligible Americans are fully vaccinated against SARS-CoV-2 as of Oct. 18, 2021, vaccine hesitancy persists.1 The U.S. Centers for Disease Control and Prevention (CDC), citing data from the U.S. Census Bureau’s Household Pulse Survey collected between May 26 and June 7, 2021, reports that in some U.S. counties—particularly in the Southeast and Northwest—between 21% and 26.7% of eligible adults said they were “vaccine hesitant.”2

You Might Also Like
  • Vaccine Hesitancy: Wariness Is Rare, But There’s a Wider Worry About COVID Vaccines’ Efficacy in Some Populations
  • CDC Says Fully Vaccinated People Can Gather Unmasked with Others Indoors
  • COVID-19 Vaccination in Patients with Rheumatic Disease
Explore This Issue
December 2021
Also By This Author
  • Pain Management Research Sheds Light on Postsurgical Pain Sensitization, Opioid Risks, Nondrug Interventions

Percentages are far lower in such areas as Southern California, between 6% and 9%. But rheumatologist Daniel G. Arkfeld, MD, says up to one-quarter of the patients at his clinic in Los Angeles are still hesitant to be vaccinated against COVID-19.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“It’s been interesting. They’re arguing with me not to get the vaccine, and I’m trying to convince them to get it,” says Dr. Arkfeld, associate professor of clinical medicine at the Keck School of Medicine, University of Southern California. “The misinformation about vaccines that is out there in the public is big. I do what I can to reason with patients, but some are adamantly opposed to the vaccines.”

Persistent Resistance

Dr. ArkfeldAlthough Dr. Arkfeld explains the benefits of the vaccines (i.e., to both prevent COVID-19 infection and limit more severe symptoms), some of his patients fear allergic reactions or a disease flare from the vaccine. Others tell him the media exaggerates COVID-19 death rates.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Some patients wanted to wait until the new vaccines were FDA approved. But when they were approved, [these patients] still wouldn’t [get vaccinated]. Some people even become angry or agitated if you try to convince them to get a vaccine,” he says.

Vaccine misinformation is widespread on social media platforms, such as Facebook, Instagram and Twitter, says Ann Marie Pettis, RN, president of the Association for Professionals in Infection Control and Epidemiology and director of infection prevention for the University of Rochester Medicine, Rochester, N.Y.

Ann Marie Pettis“Patients are greatly influenced by what they hear from friends and relatives, and what they see on TV and social media—each with their own biases that distort the fact that the Covid-19 vaccines are safe, effective and free,” Ms. Pettis says. “Instead, patients should put their trust in their healthcare professionals, who understand germ-caused diseases and how to prevent them. We know that the vaccine works and that Covid-19 kills, so the more of us who get vaccinated, the less chance there is for new variants to emerge, and the quicker we can all get our normal lives back.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Arkfeld says he finds the ACR’s COVID-19 Vaccine Clinical Guidance Summary for Patients with Rheumatic and Musculoskeletal Diseases helpful when he explains vaccine efficacy or risk of flare to patients on immunomodulatory therapies.

Also to help with conversations with patients, The Rheumatologist has created a printable, one-page handout on common COVID-19 vaccine myths and facts that rheumatologists and clinical staff can share and discuss with patients.


Susan Bernstein is a freelance journalist based in Atlanta.

Pages: 1 2 3 | Single Page

Filed Under: Patient Perspective Tagged With: COVID-19, vaccination, vaccine hesitancyIssue: December 2021

You Might Also Like:
  • Vaccine Hesitancy: Wariness Is Rare, But There’s a Wider Worry About COVID Vaccines’ Efficacy in Some Populations
  • CDC Says Fully Vaccinated People Can Gather Unmasked with Others Indoors
  • COVID-19 Vaccination in Patients with Rheumatic Disease
  • COVID-19 Vaccination Strategies Suggested for Patients on Anti-Rheumatic Immunosuppressive Therapy

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)